The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Caris Life Sciences
Leadership - Caris Life Sciences
Consulting or Advisory Role - Merck Sharp & Dohme
Travel, Accommodations, Expenses - Merck Sharp & Dohme
Large scale multiomic analysis suggests mechanisms of resistance to immunotherapy in leiomyosarcoma.
 
Galina Lagos
No Relationships to Disclose
 
Roman Groisberg
Honoraria - Regeneron
Speakers' Bureau - Rockpointe CME; TotalCME
 
Don S. Dizon
Stock and Other Ownership Interests - InfiniteMD; NeuHope
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; i-Mab; Regeneron; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Kazia Therapeutics (Inst); Merck Sharp & Dohme (Inst); Tesaro (Inst)
 
Andrew Elliott
Employment - Caris Life Sciences
 
Tabitha Copeland
No Relationships to Disclose
 
Andreas Seeber
Consulting or Advisory Role - Caris Life Sciences
Travel, Accommodations, Expenses - Caris Life Sciences
 
Geoffrey Thomas Gibney
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Jounce Therapeutics; Newlink Genetics; Novartis; Regeneron
Research Funding - Exelixis
Other Relationship - Genentech
 
Margaret von Mehren
Consulting or Advisory Role - deciphera; Exelixis
Research Funding - Arog (Inst); ArQule; ASCO (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Lilly (Inst); Novartis (Inst); Springworks Therapeutics (Inst)
Travel, Accommodations, Expenses - Deciphera; NCCN
Other Relationship - NCCN
 
Kenneth Cardona
No Relationships to Disclose
 
Michael J. Demeure
Consulting or Advisory Role - Avant Diagnostics; Bayer; Loxo/Lilly; Orphagen Pharmaceuticals; TD2
(OPTIONAL) Uncompensated Relationships - transmed7
 
Richard F. Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi Sankyo; Deciphera; Ignyta; Loxo; NanoCarrier; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Bayer (Inst); Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); NanoCarrier (Inst); Philogen (Inst); Plexxikon (Inst); Roche/Genentech (Inst); SpringWorks Therapeutics (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Ignyta; NanoCarrier
 
Vaia Florou
No Relationships to Disclose
 
Alexander J. Chou
No Relationships to Disclose
 
Abhijeet Kumar
Stock and Other Ownership Interests - Merck; TG Therapeutics
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - Takeda
 
Jaime Modiano
Honoraria - ImmunityBio
Research Funding - Boston Scientific
Patents, Royalties, Other Intellectual Property - Anivive Lifesciences; Boston Scientific; Kerafast
 
Moh'd M. Khushman
Stock and Other Ownership Interests - Aprea therapeutics; Blueprint Medicines; Cardiff Oncology; Daiichi Sankyo; Global Blood Therapeutics; Guardant Health; Halozyme; Moderna Therapeutics; Regeneron
Consulting or Advisory Role - AstraZeneca; Taiho Pharmaceutical
Speakers' Bureau - AstraZeneca; Pfizer
 
Gina Z. D'Amato
Consulting or Advisory Role - Blueprint Medicines; Deciphera; Epizyme
Speakers' Bureau - Janssen Oncology; Lilly
 
Andrea P. Espejo Freire
No Relationships to Disclose
 
W. Michael Korn
No Relationships to Disclose
 
Jonathan C. Trent
Consulting or Advisory Role - Agios; Bayer; Blueprint Medicines; C4 Therapeutics; Daiichi Sankyo; Deciphera; Epizyme; Janssen; Lilly; Novartis